Trials / Completed
CompletedNCT00980629
Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
A Randomized, Placebo-Controlled, Double-blind, Parallel Group, Multi-centre Phase II Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
This study is to investigate the efficacy and safety of M516102 and to evaluate the dose response relationship of M516102 and placebo, in the treatment of pruritus associated with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | M516102 | Twice a day |
| DRUG | placebo | Twice a day |
Timeline
- Start date
- 2008-08-01
- Completion
- 2010-09-01
- First posted
- 2009-09-21
- Last updated
- 2010-11-03
Locations
4 sites across 4 countries: France, Germany, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT00980629. Inclusion in this directory is not an endorsement.